Loading insider details...
Beta
Latest Form 4 (Aug 5, 2024): Tender of Shares of 27,349,211 CERE shares, $1.23B.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 5, 2024 | Cerevel Therapeutics Holdings, Inc. (CERE) | Tender of Shares | 27,349,211 | $1.23B |
| Mar 21, 2023 | Pyxis Oncology, Inc. (PYXS) | Purchase | 1,811,594 | $5.00M |
| Dec 22, 2020 | BioAtla, Inc. (BCAB) | Conversion | 2,238,090 | n/a |
| Nov 16, 2020 | Viatris Inc (VTRS) | Other (see footnotes) | 689,873,947 | n/a |
| Oct 29, 2020 | Cerevel Therapeutics Holdings, Inc. (CERF) | Purchase | 1,200,000 | $12.00M |
| Jun 4, 2020 | Cortexyme, Inc. (CRTX) | Sale | 370,000 | $14.87M |
| Mar 16, 2020 | IMARA Inc. (IMRA) | Conversion | 76,003 | n/a |